Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $308.15M.
ENTERPRISE VALUE (EV)
$308.15M
Fate Therapeutics, Inc.
Market Cap
$281.49M
Enterprise Value (EV)
$308.15M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Fate Therapeutics, Inc. (FATE) | $281.49M | $308.15M |
| Aurora Cannabis Inc. (ACB)vs › | $281.22M | $213.81M |
| Indaptus Therapeutics, Inc. (INDP)vs › | $282.54M | $274.98M |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $283.44M | $240.26M |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $273.56M | $185.47M |
| Abeona Therapeutics Inc. (ABEO)vs › | $289.25M | $252.89M |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $267.84M | $217.35M |
| OraSure Technologies, Inc. (OSUR)vs › | $266.79M | $118.30M |
| Standard BioTools Inc. (LAB)vs › | $292.50M | $50.56M |
| Larimar Therapeutics, Inc. (LRMR)vs › | $293.66M | $205.93M |
Market Cap
$281.49M
Total Debt
$73.29M
Cash
$46.63M
Enterprise Value
$308.15M
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Why use EV instead of Market Cap?
